[CLSTR]
< Back to situation

[REVISION HISTORY]

Poland pharmaceutical regulation and cost reforms

Updated 7 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-09 15:44 UTC → 2026-09-09 21:27 UTC · added removed

By late August 2026, the Ministry of Health introduced measures to manage the National Health Fund deficit and drug security. To address rising costs, the Ministry planned to reduce the list of free medications for seniors aged 65 and older, potentially removing up to 1,500 items if manufacturers do not lower prices. To combat pharmaceutical waste, new prescription regulations were proposed, including limits on treatment days per prescription and individual reimbursement accounts. Regarding advertising, the government continued drafting amendments to the Pharmaceutical Law to align with a CJEU ruling. These changes aim to replace a total ban with specific restrictions against misleading ads or targeting minors, though authorities warned of a regulatory gap during implementation. Additionally, following industry pushback regarding economic and constitutional concerns, the Ministry withdrew a proposal to drastically increase financial penalties for violations related to dietary supplements and fortified foods. In September 2026, new strategic directions were presented at the Karpacz Economic Forum under a new ‘Drug Policy’ framework. This framework aims to increase pharmaceutical security by creating regulations for drug supply during wartime and simplifying vaccinations through a ‘single window’ system. The Ministry also proposed replacing the current reimbursement budget with a multi-year financial plan for pharmacy drugs and chemotherapy programs. To prevent Regarding the misuse of over-the-counter (OTC) medications, senior medication list, the Ministry plans clarified that while approximately 1,500 commercial products may be removed by October 2026, seniors will not lose access to establish a central register necessary active substances, as they will instead receive free generic equivalents. To qualify for drugs containing codeine, pseudoephedrine, and dextromethorphan, tracked via free medication, patients must be at least 65, the PESEL system. Furthermore, officials are considering mandatory price caps for unique therapies and increased wholesale margins. Parallel to these efforts, ten institutions signed a declaration to report drug must be on necessary management reforms to improve the efficiency of public health institutions. official list, and the prescription must include the ‘S’ symbol, which can be issued by primary care physicians, specialists, or authorized nurses.

Versions

  1. 2026-09-09 21:27 UTC Poland pharmaceutical regulation and cost reforms
  2. 2026-09-09 15:44 UTC Poland pharmaceutical regulation and cost reforms
  3. 2026-09-02 21:11 UTC Poland pharmaceutical regulation and cost reforms
  4. 2026-09-01 09:23 UTC Poland pharmaceutical regulation and cost reforms
  5. 2026-08-31 05:53 UTC Poland pharmaceutical regulation and cost reforms
  6. 2026-08-24 07:25 UTC Poland pharmaceutical regulation reforms
  7. 2026-08-11 17:03 UTC Poland pharmaceutical regulation reforms
  8. 2026-08-07 23:13 UTC Poland pharmaceutical regulation reforms

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.